161 related articles for article (PubMed ID: 6391658)
21. Adjuvant immune stimulation with Corynebacterium parvum during maintenance chemotherapy of acute myeloid leukemia. A prospective randomized study.
la Cour Petersen E; Hokland P; Ellegaard J
Cancer Immunol Immunother; 1983; 16(2):88-92. PubMed ID: 6420046
[TBL] [Abstract][Full Text] [Related]
22. [Combination chemotherapy of N(4)-behenoyl-1-beta-arabinofuranosylcytosine, aclarubicin, 6-MP, and prednisolone (BH-AC. AMP therapy) for adult acute non-lymphocytic leukemia].
Ishige K; Takagi T; Oguro M
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1475-9. PubMed ID: 6588925
[TBL] [Abstract][Full Text] [Related]
23. Immunotherapy with bestatin for acute nonlymphocytic leukemia in adults.
Ota K; Kurita S; Yamada K; Masaoka T; Uzuka Y; Ogawa N
Cancer Immunol Immunother; 1986; 23(1):5-10. PubMed ID: 3533256
[TBL] [Abstract][Full Text] [Related]
24. Standard induction chemotherapy followed by attenuated consolidation in elderly patients with acute myeloid leukemia.
Lee JH; Choi SJ; Lee JH; Park JH; Kim H; Joo YD; Lee WS; Zang DY; Kim HJ; Lee KH;
Ann Hematol; 2006 Jun; 85(6):357-65. PubMed ID: 16575580
[TBL] [Abstract][Full Text] [Related]
25. Daunomycin, cytosine arabinoside and 6-thioguanine (DAT) vs vincristine, cytosine arabinoside and 6-thioguanine (VAT) in the induction treatment of acute nonlymphocyte leukemia: a randomized collaborative study.
Mandelli F; De Lipsis E; Grignani F; Martelli M; Liso V; Amadori S
Med Pediatr Oncol; 1978; 4(3):231-40. PubMed ID: 277749
[TBL] [Abstract][Full Text] [Related]
26. Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group.
Büchner T; Urbanitz D; Hiddemann W; Rühl H; Ludwig WD; Fischer J; Aul HC; Vaupel HA; Kuse R; Zeile G
J Clin Oncol; 1985 Dec; 3(12):1583-9. PubMed ID: 3906048
[TBL] [Abstract][Full Text] [Related]
27. Etoposide in acute nonlymphocytic leukemia. Australian Leukemia Study Group.
Bishop JF; Lowenthal RM; Joshua D; Matthews JP; Todd D; Cobcroft R; Whiteside MG; Kronenberg H; Ma D; Dodds A
Blood; 1990 Jan; 75(1):27-32. PubMed ID: 2403818
[TBL] [Abstract][Full Text] [Related]
28. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy.
Fisher M; Yang LX
Anticancer Res; 2002; 22(3):1737-54. PubMed ID: 12168863
[TBL] [Abstract][Full Text] [Related]
29. Busulfan/etoposide--initial experience with a new preparatory regimen for autologous bone marrow transplantation in patients with acute nonlymphoblastic leukemia.
Chao NJ; Stein AS; Long GD; Negrin RS; Amylon MD; Wong RM; Forman SJ; Blume KG
Blood; 1993 Jan; 81(2):319-23. PubMed ID: 8422458
[TBL] [Abstract][Full Text] [Related]
30. Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol.
Berman E; Arlin ZA; Gaynor J; Miller W; Gee T; Kempin SJ; Mertelsmann R; Andreeff M; Reich L; Nahmias N
Leukemia; 1989 Feb; 3(2):115-21. PubMed ID: 2911205
[TBL] [Abstract][Full Text] [Related]
31. Childhood acute nonlymphocytic leukemia in 88 patients.
Hung IJ; Yang CP; Jiang TH
J Formos Med Assoc; 1994 Jun; 93(6):469-74. PubMed ID: 7858434
[TBL] [Abstract][Full Text] [Related]
32. [Results of follow-up studies on prognosis after immunotherapy with bestatin in acute nonlymphocytic leukemia].
Ota K; Kurita S; Yamada K; Masaoka T; Uzuka Y; Ogawa N
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1017-25. PubMed ID: 3963846
[TBL] [Abstract][Full Text] [Related]
33. Ubenimex in the treatment of acute nonlymphocytic leukemia in adults.
Urabe A; Mutoh Y; Mizoguchi H; Takaku F; Ogawa N
Ann Hematol; 1993 Aug; 67(2):63-6. PubMed ID: 8347731
[TBL] [Abstract][Full Text] [Related]
34. High-dose cytosine arabinoside as consolidation chemotherapy for acute nonlymphocytic leukemia in remission.
Urabe A; Mizoguchi H; Hoshino S; Nomura T; Dan K; Toyama K; Kimura M; Ogawa T; Yamaguchi H; Mutoh Y
Int J Hematol; 1991 Feb; 54(1):75-7. PubMed ID: 1954354
[TBL] [Abstract][Full Text] [Related]
35. Peripheral neuropathy after high-dose cytosine arabinoside, daunorubicin, and asparaginase consolidation for acute nonlymphocytic leukemia.
Powell BL; Capizzi RL; Lyerly ES; Cooper MR
J Clin Oncol; 1986 Jan; 4(1):95-7. PubMed ID: 3001234
[TBL] [Abstract][Full Text] [Related]
36. Probability of long-term disease-free survival for acute myeloid leukemia patients after first relapse: A single-centre experience.
Vignetti M; Orsini E; Petti MC; Moleti ML; Andrizzi C; Pinto RM; Amadori S; Meloni G
Ann Oncol; 1996 Nov; 7(9):933-8. PubMed ID: 9006744
[TBL] [Abstract][Full Text] [Related]
37. Therapy of acute myelogenous leukemia in patients over the age of 50: a randomized Southeastern Cancer Study Group trial.
Stein RS; Vogler WR; Winton EF; Cohen HJ; Raney MR; Bartolucci A
Leuk Res; 1990; 14(10):895-903. PubMed ID: 2259226
[TBL] [Abstract][Full Text] [Related]
38. Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG).
de Witte T; Suciu S; Peetermans M; Fenaux P; Strijckmans P; Hayat M; Jaksic B; Selleslag D; Zittoun R; Dardenne M
Leukemia; 1995 Nov; 9(11):1805-11. PubMed ID: 7475266
[TBL] [Abstract][Full Text] [Related]
39. [Therapy of malignant systemic diseases: hemoblastoses and malignant lymphomas].
Schmidt CG
Arzneimittelforschung; 1987 Feb; 37(2A):279-87. PubMed ID: 3551972
[TBL] [Abstract][Full Text] [Related]
40. Donor leucocyte infusions after chemotherapy for patients relapsing with acute leukaemia following allogeneic BMT.
Szer J; Grigg AP; Phillips GL; Sheridan WP
Bone Marrow Transplant; 1993 Feb; 11(2):109-11. PubMed ID: 8435660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]